Caisson Biotech

Caisson Biotech has developed a novel heparin-based drug delivery platform, Heptune, to enhance therapeutic efficacy. Caisson Biotech, LLC is a collaboration-driven biotechnology company specializing in the development of heparin polymers to improve the delivery and performance of therapeutic drugs. Founded in 2009, Caisson Biotech is a subsidiary of Heparinex, LLC and is managed by Emergent Technologies, Inc., a leading life science technology management company based in Austin, Texas, USA.